Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

First clinical data on peptide for autoimmune diabetes presented during EASD meeting

Sep. 14, 2001

New glucose transport stimulator under study at Korean centers

Sep. 14, 2001

Novartis launches NAVIGATOR trial for diabetes and cardiovascular disease prevention

Sep. 14, 2001

Stimulation of exocytosis from pancreatic beta-cells by imidazolines is PLA2-dependent

Sep. 14, 2001

Oralin is a suitable substitute for injected insulin according to EASD presentations

Sep. 14, 2001

Antifibrotic compounds the focus of a FibroGen/Sankyo collaboration

Sep. 14, 2001

Pump therapy with insulin aspart approved by EMEA

Sep. 14, 2001

Atrix licenses novel growth-promoting peptide from Tulane

Sep. 14, 2001

Oral insulin sensitizer RWJ-241947/MCC-555 tested in animal models of type 2 diabetes

Sep. 13, 2001

Danish investigators report clinical results for stevioside in diabetes at EASD

Sep. 13, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.